BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27628691)

  • 1. An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C).
    Swingle M; Volmar CH; Saldanha SA; Chase P; Eberhart C; Salter EA; D'Arcy B; Schroeder CE; Golden JE; Wierzbicki A; Hodder P; Honkanen RE
    SLAS Discov; 2017 Jan; 22(1):21-31. PubMed ID: 27628691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
    Swingle MR; Honkanen RE
    Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
    Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
    J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High yield expression of serine/threonine protein phosphatase type 5, and a fluorescent assay suitable for use in the detection of catalytic inhibitors.
    Ni L; Swingle MS; Bourgeois AC; Honkanen RE
    Assay Drug Dev Technol; 2007 Oct; 5(5):645-53. PubMed ID: 17939754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approaches.
    Sotoud H; Gribbon P; Ellinger B; Reinshagen J; Boknik P; Kattner L; El-Armouche A; Eschenhagen T
    J Biomol Screen; 2013 Sep; 18(8):899-909. PubMed ID: 23606651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
    Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
    Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ultra-high throughput cell-based screen for wee1 degradation inhibitors.
    Madoux F; Simanski S; Chase P; Mishra JK; Roush WR; Ayad NG; Hodder P
    J Biomol Screen; 2010 Sep; 15(8):907-17. PubMed ID: 20660794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PP1:Tautomycetin Complex Reveals a Path toward the Development of PP1-Specific Inhibitors.
    Choy MS; Swingle M; D'Arcy B; Abney K; Rusin SF; Kettenbach AN; Page R; Honkanen RE; Peti W
    J Am Chem Soc; 2017 Dec; 139(49):17703-17706. PubMed ID: 29156132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and implementation of a miniaturized high-throughput time-resolved fluorescence energy transfer assay to identify small molecule inhibitors of polo-like kinase 1.
    Sharlow ER; Leimgruber S; Shun TY; Lazo JS
    Assay Drug Dev Technol; 2007 Dec; 5(6):723-35. PubMed ID: 18181689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
    Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
    Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein phosphatase interacting proteins from normal and UVA-irradiated HaCaT cell lysates by surface plasmon resonance based binding technique using biotin-microcystin-LR as phosphatase capturing molecule.
    Bécsi B; Dedinszki D; Gyémánt G; Máthé C; Vasas G; Lontay B; Erdődi F
    J Photochem Photobiol B; 2014 Sep; 138():240-8. PubMed ID: 24993084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactor-guided dephosphorylation by protein phosphatase-1.
    Boens S; Szekér K; Van Eynde A; Bollen M
    Methods Mol Biol; 2013; 1053():271-81. PubMed ID: 23860659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel high-throughput deoxyribonuclease 1 assay.
    Jang DS; Penthala NR; Apostolov EO; Wang X; Fahmi T; Crooks PA; Basnakian AG
    J Biomol Screen; 2015 Feb; 20(2):202-11. PubMed ID: 25326282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
    Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
    Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogeneous screening assay for human tankyrase.
    Narwal M; Fallarero A; Vuorela P; Lehtiö L
    J Biomol Screen; 2012 Jun; 17(5):593-604. PubMed ID: 22357873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate and penta-O-galloyl-β-D-glucose inhibit protein phosphatase-1.
    Kiss A; Bécsi B; Kolozsvári B; Komáromi I; Kövér KE; Erdődi F
    FEBS J; 2013 Jan; 280(2):612-26. PubMed ID: 22260360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated Peptide Derived from the Myosin Phosphatase Target Subunit Is a Novel Inhibitor of Protein Phosphatase-1.
    Kónya Z; Tamás I; Bécsi B; Lontay B; Raics M; Timári I; Kövér KE; Erdődi F
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
    Dancheck B; Nairn AC; Peti W
    Biochemistry; 2008 Nov; 47(47):12346-56. PubMed ID: 18954090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.